Extraordinary Genius

Pfizer, but the world's leading pharmaceutical company, although not the largest in the world, is much more than a few others. Founded in the middle of the last century, it was initially a small company that made chemical products. Later, he marched into the field of chemical pharmaceuticals, and then, during the Civil War in the United States, he made a fortune and became one of the bigger chemical manufacturing companies in the United States.

Later, antibiotics were discovered, Pfizer entered the field of antibiotic manufacturing and grew into one of the pioneers of fermentation technology, which also further strengthened the company.

That was when World War II broke out, as Pfizer was able to provide cheap penicillin, making it the biggest supplier of penicillin for the US Army in World War II, and the company was taken off again.

Later, the company developed a broad spectrum of antibiotics, including tetracycline and pyrroxicam, all of which made huge profits to Pfizer.

It is worth mentioning that most of Huaxia's doxorubicin, tetracycline, etc. are also produced by Pfizer. And because tetracycline is inexpensive, it works well, it is widely used, resulting in a batch of... tetracycline teeth!

After Pfizer discovered the benefits of drug R&D, it invested a lot of money in it, and the direction of R&D was the most demanding drug on the market.

Antihypertensives, cholesterol-lowering drugs, rheumatologies, analgesics, anti-inflammatory drugs and their leading antibiotics all over the world, of course, including some anticancer drugs.

And Pfizer's results are also very encouraging, with new medicines constantly being introduced, each of which brings great profits to the company.

Pfizer can be one of the giants because they have a lot of patented formulations of drugs that can make them huge profits over the course of 20 years of drug protection. And even after the protection period, they can still guarantee price advantages because they have the most mature production methods.

Together with their brand effectiveness, they will still be able to continually profit from these medicines.

How is it possible that this Feng boss is buying their patented pharmaceutical formula? When did you hear Pfizer would sell its own patented formula? Unless it's almost the patent protection period, that's all that's possible.

“Mr. Feng, I can't take the lead on this, because the pharmaceutical patent formula is the company's most important asset.” Victor hesitated to say.

Feng Yu looked very dissatisfied: “Wealth, isn't it used to sell money? How do you know the company won't agree if you haven't heard of my offer? Besides, haven't you ever sold a patented formula? ”

Feng Yu's words are rough, but they do make sense. Research and development of pharmaceutical formulations, patent applications, to create wealth, not at all what they promote for the benefit of patients, if selling a high price at this time, seems good.

But at present, the pharmaceuticals developed by the company are all after the company's research. How can you sell the patented formula if you think that there is a huge demand in the market?

But you can't sell it. Maybe you can authorize it? Perhaps the company could offer him a lot of rewards if he could come up with a heavenly license fee. Money is secondary, and it is of the utmost importance that he be transferred back to the United States and reunited with his family.

“We haven't sold the patented formula, but we've licensed it to other companies. If Mr. Feng wants patent authorization, he can still talk about it.” Victor said cunningly.

Patent authorization? Shit, isn't that what you make? You took most of it. Ice City Pharmaceuticals also has its own pharmaceutical research and development laboratory, and now there are a number of professional research and development personnel who do not need to buy each other's patent licenses.

Feng Yu is looking at a drug that Pfizer is currently about to develop successfully, a drug that you find “side effects" more effective than the original R&D direction - Van Eko!

This is a new drug that Pfizer studied to treat angina, antithrombotic, suppress hypertension and other effects. When it was developed, it was found in clinical trials that the efficacy of the drug was frustrating.

It can be said that it is a total failure. There is no market for medicines with minimal efficacy.

But they found that many clinical experimenters were hiding the drug, and some daring researchers took it themselves before discovering the “side effects" of the drug, which can make men frequent * * *.

R&D staff decided to redirect R&D as a drug to treat * * * dysfunction, and Pfizer also conducted nearly three years of market research after the report was submitted.

Until the beginning of this year, when the experiment really started, it turned out to be surprising, and basically 80 percent of the people who took it had noticeable improvement.

Previously, there were no similar medicines, but they were all injected, and the effect of the injection was not so good. Who's interested in giving themselves a shot before work?

Feng Yu had previously sent someone to contact Pfizer to see if he could buy the drug formula, but found that the other party was already conducting a clinical trial, which means that when he wanted to buy it, it was too late.

How could a world-class company like Pfizer want to buy pharmaceutical formulations with a little money? Although Feng Yu has already offered a high price, the other party has not agreed, the caliber is the same as Victor's, if the patent can be licensed in the future, but the formula will not be sold.

How can Feng Yu be satisfied with patent licensing? He wants more. He wants to turn this medicine into his own. But now it looks very difficult, Feng Yu can only set up one inning.

“Victor, do you think I'd be the one paying the patent royalties? What I want is to buy some formulas, some formulas to treat diseases, treat any disease, semi-finished products, I don't choose. The price will definitely satisfy you.” Feng Yuda grinned.

Feng Yu only knows that Wan Ai is a PDE5 inhibitor, and not only was there one Wan Aiko in previous life, but at least two similar drugs. Feng Yu just needs to buy the formula for the PDE5 inhibitor, how to research it later, that would be much simpler.

And with formulas, Feng Yu can guarantee that the pharmaceuticals produced by Iceland Pharmaceuticals can be marketed earlier than Pfizer, because Huaxia is less strictly regulated than the US, and the world's number one title will be taken by Iceland Pharmaceuticals, and the future sales of pharmaceuticals will definitely be better than other companies.

Victor heard Feng Yu's words and moved in his heart. A semi-finished product? Doesn't that mean the company has a lot of failed prescriptions and can sell them to him?

This Feng boss, so rich, typical people have a lot of silly money, if he can sell some semi-finished products to him and reduce the company's R&D costs, then he is not a big success?

With this credit, he should be able to apply for a transfer back to the United States, right?

“Mr. Feng, if the semi-finished product works, I can ask. ”